Cell Signaling Technology

SIGMAR1 (D4J2E) Rabbit Monoclonal Antibody

#61994 · $159,351

7
Citing papers
78
Combined citations
Supplier page Find this product

Research areas

Pharmacological Receptor Mechanisms and Effects5Receptor Mechanisms and Signaling2Tryptophan and brain disorders2Autophagy in Disease and Therapy2Long-Term Effects of COVID-191Nanoplatforms for cancer theranostics1Parkinson's Disease Mechanisms and Treatments1Peptidase Inhibition and Analysis1

Papers citing this product

1
Sigma-1 receptor activation mediates the sustained antidepressant effect of ketamine in mice via increasing BDNF levels
Acta Pharmacologica Sinica·2023·23 cit.·DOI
2
Study of the Relationship between Sigma Receptor Expression Levels and Some Common Sigma Ligand Activity in Cancer Using Human Cancer Cell Lines of the NCI-60 Cell Line Panel
Biomedicines·2021·17 cit.·DOI
3
The Protective Role of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Protein Sigma-1 Receptor in Regulating Endothelial Inflammation and Permeability Associated with Acute Lung Injury
Cells·2023·10 cit.·DOI
4
Yiqi Huoxue preserves heart function by upregulating the Sigma‑1 receptor in rats with myocardial infarction
Experimental and Therapeutic Medicine·2021·10 cit.·DOI
5
SARS-CoV-2 NSP6 reduces autophagosome size and affects viral replication via sigma-1 receptor
Journal of Virology·2024·9 cit.·DOI
6
Sigma1 inhibitor suppression of adaptive immune resistance mechanisms mediated by cancer cell derived extracellular vesicles
Cancer Biology & Therapy·2025·6 cit.·DOI
7
The ultrastructural and proteomic analysis of mitochondria‐associated endoplasmic reticulum membrane in the midbrain of a Parkinson's disease mouse model
Aging Cell·2024·3 cit.·DOI

Similar products

ProductVendorEvidencePricePapers
SIGMAR1 (D7L1M) Rabbit Monoclonal AntibodyRabbitCell Signaling Technology—$161,3511

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.